Skip to main content
    I

    Ideaya Biosciences Inc (IDYA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $30.36
    -1.47 (-4.62%)

    Market Cap: $3.08B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Ideaya Biosciences Inc (IDYA) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Ideaya Biosciences are Iovance Biotherapeutics (IOVA), Legend Biotech (LEGN) and Ionis Pharmaceuticals (IONS). By market cap, Ideaya Biosciences ranks 9th of the 13 companies on this page; Cogent Biosciences (COGT) is the largest at $4.97B.

    Peer Comparison

    IDYA's revenue growth of -95.1% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Ideaya Biosciences (IDYA)$3.08BN/A85.5x0.0%N/A-95.1%0.00%
    Iovance Biotherapeutics Inc (IOVA)$3.59BN/A9.1x-58.2%N/A80.1%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Ionis Pharmaceuticals Inc (IONS)$4.84BN/A4.8x-56.9%-29.3%54.9%0.00%
    Dyne Therapeutics Inc (DYN)$3.22BN/AN/A0.0%-42.9%0.0%0.00%
    MBX Biosciences, Inc. Common Stock (MBX)$2.78BN/AN/A0.0%N/A0.0%0.00%
    Disc Medicine Inc. (IRON)$3.64BN/AN/A0.0%-40.0%0.0%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    Xencor Inc (XNCR)$2.78BN/A13.5x-58.8%-17.3%454.9%0.00%
    Cogent Biosciences Inc (COGT)$4.97BN/AN/A0.0%-43.4%-100.0%0.00%
    Viridian Therapeutics Inc (VRDN)$3.51BN/A128.5x0.0%-41.8%-63.5%0.00%
    Denali Therapeutics Inc (DNLI)$3.00BN/A159.3x0.0%N/A-100.0%0.00%
    Tango Therapeutics Inc (TNGX)$4.32BN/AN/A0.0%N/A-100.0%0.00%
    Peer median$3.45B266.5x13.5x0.0%-40.0%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Ideaya Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Iovance Biotherapeutics Inc (IOVA)
    Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness...
    IOVA competitors
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Ionis Pharmaceuticals Inc (IONS)
    Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
    IONS competitors
    Dyne Therapeutics Inc (DYN)
    Dyne Therapeutics, Inc., a muscle disease company, is a biotechnology company focused on advancing therapeutics for genetically-derived muscle diseases...
    DYN competitors
    MBX Biosciences, Inc. Common Stock (MBX)
    MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment...
    MBX competitors
    Disc Medicine Inc. (IRON)
    Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development...
    IRON competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    Xencor Inc (XNCR)
    Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed...
    XNCR competitors
    Cogent Biosciences Inc (COGT)
    Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases.
    COGT competitors
    Viridian Therapeutics Inc (VRDN)
    Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses.
    VRDN competitors
    Denali Therapeutics Inc (DNLI)
    Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States.
    DNLI competitors
    Tango Therapeutics Inc (TNGX)
    Tango Therapeutics Inc. is a leading clinical-stage biotechnology firm at the forefront of cancer treatment innovation...
    TNGX competitors

    Frequently Asked Questions About IDYA

    Who are Ideaya Biosciences' main competitors?

    The companies most similar to Ideaya Biosciences include Iovance Biotherapeutics (IOVA), Legend Biotech (LEGN), Ionis Pharmaceuticals (IONS), Dyne Therapeutics (DYN) and MBX Biosciences, Inc. Common Stock (MBX), listed from the closest match.

    Who is Ideaya Biosciences' biggest competitor?

    Cogent Biosciences (COGT) is the largest of the similar companies at $4.97B; Iovance Biotherapeutics (IOVA) is the closest match by business profile, size, sector and industry.

    How does IDYA stock compare with its competitors?

    IDYA's P/S is 85.5x against a peer median of 13.5x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Ideaya Biosciences' competitors pays a higher dividend?

    Ideaya Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Ideaya Biosciences bigger than its competitors?

    No. Ideaya Biosciences is 9th by market cap among the 13 companies on this page; the largest is Cogent Biosciences (COGT) at $4.97B.